CLINICAL_TRIALS
trial_result
· 2013-03-26
Clinical Trial Update: RPI.4610 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Summary
Phase 2 trial update showing RPI.4610 in metastatic renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ribozyome | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED